Your session is about to expire
← Back to Search
Enhanced Cognitive Behavioral Therapy for Depression (CBT+ Trial)
CBT+ Trial Summary
This trial will investigate whether exercising before therapy sessions can improve the effects of cognitive behavioral therapy on depression.
CBT+ Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CBT+ Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the registration process for this trial still open?
"According to clinicaltrials.gov, this clinical trial is currently searching for individuals to participate in the study which was initially posted on September 1st 2023 and last modified on September 26th 2023."
Is this clinical experiment limited to persons under 35, or are those of more advanced age also eligible?
"For this clinical trial, the age range for potential participants falls between 18 and 65. Nevertheless, there are over 200 studies available to those below 18 years of age, with 1,021 options for individuals aged beyond 65."
What is the upper limit of individuals engaging in this examination?
"Affirmative. Clinicaltrials.gov's information indicates that this clinical trial is currently recruiting patients, with 40 participants being sought out from 1 location since its first posting on September 1st 2023 and last update on the 26th of the same month."
What are the major goals of this clinical experiment?
"This clinical trial's primary outcome to be measured during Weeks 1-8 of CBT+ visits is the Average change in self-reported behavioral activation as assessed by the Behavioral Activation for Depression Scale (BADS). Additional outcomes encompass a Change in suicidal thoughts using Columbia-Suicide Severity Rating Scale (CSSRS) which has 5 ordinal points from 'wish to be dead' to 'suicidal intent with plan', an Average Anhedonia score measured through an Anhedonia Visual Analog Scale, and finally Serum Brain Derived Neurotrophic Factor (BDNF) checked via Enzyme Linked Immunosorbent Ass"
Could I be a viable participant in this clinical experiment?
"This medical trial seeks 40 patients aged 18-65 diagnosed with DSM-5 Major Depressive Disorder (MDD) according to the Structured Clinical Interview for DSM-5. The participants should present current depressive symptoms of at least mild severity, and they must not be engaging in any mental health treatment or have a stable regimen that will remain unchanged throughout the duration of the intervention. Additionally, all applicants must pass a Physical Activity Readiness Questionnaire and never had structured Cognitive Behavioral Therapy (CBT)."
Share this study with friends
Copy Link
Messenger